What is NDC 72238-001?

72238-001 is the product NDC for Vamousse Lice Treatment (pediculicide), Sodium chloride 2 [hp_X]/mL aerosol, foam, listed with the FDA by Alliance Pharma Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Vamousse Lice Treatment (Pediculicide).

Alliance Pharma Inc., NDC labeler code 72238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Vamousse Lice Treatment?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Vamousse Lice Treatment NDC 72238-001 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72238-001Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72238-0001Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72238-001-01	72238000101	1 BOTTLE, WITH APPLICATOR in 1 BOX (72238-001-01) / 177 mL in 1 BOTTLE, WITH APPLICATORMarketed from Oct 1, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Vamousse Lice Treatment
Generic name (nonproprietary): pediculicide
Active ingredients: Sodium chloride — 2 [hp_X]/mL
Dosage form: Aerosol, Foam
Route: Topical
Labeler: Alliance Pharma Inc.NDC labeler code 72238
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Oct 1, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)
Identifiers: Product ID 72238-001_45371982-daac-f344-e063-6394a90a2f41SPL ID 45371982-daac-f344-e063-6394a90a2f41SPL set ID 75db3fab-5523-4880-e053-2a91aa0a925eUNII 451W47IQ8XUPC 0358962000010
Pharmacologic class: Osmotic Laxative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472238000101 followed by a unit qualifier and the quantity

Package 72238-0001-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 5, 2025.

Indications (excerpt from the label)

Uses Treats head lice infestation

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72238-001

What is NDC 72238-001?: 72238-001 is the product NDC for Vamousse Lice Treatment (pediculicide), Sodium chloride 2 [hp_X]/mL aerosol, foam, listed with the FDA by Alliance Pharma Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Vamousse Lice Treatment (Pediculicide).
What is the active ingredient?: Sodium chloride.
Who is the labeler?: Alliance Pharma Inc., NDC labeler code 72238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Vamousse Lice Treatment?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Vamousse Lice Treatment (Pediculicide) NDC 72238-001